Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps : results from the SINUS-24 and SINUS-52 phase 3 trials

Authors
Publication date
1 January 2021
Publisher
'American Thoracic Society'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ghent University Academic Bibliography

    redirect
    oaioai:archive.ugent.be:8747044
    Last time updated on 13/11/2022